Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,512,424
+$3,315,837 QoQ
Shares Held
554,832
-20.8% QoQ
Ownership
0.211%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $19,103,501,096 across 19 Drug Manufacturers - General names. OGN ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,646,119 | $5,572,694,974 | |
| 2 | JNJ |
Johnson & Johnson
|
17,374,433 | $4,412,584,747 | |
| 3 | AMGN |
Amgen Inc
|
7,235,462 | $2,620,105,497 | |
| 4 | ABBV |
AbbVie Inc.
|
9,017,580 | $2,269,183,828 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,658,434 | $1,498,108,767 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
6,439,586 | $813,577,293 | |
| 7 | PFE |
Pfizer Inc
|
20,193,675 | $486,263,691 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,321,643 | $364,253,067 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,512,424 | 554,832 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,196,587 | 700,599 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $6,531,066 | 910,888 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,767,688 | 352,780 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,906,914 | 403,607 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,310,533 | 289,492 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,920,169 | 262,746 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,909,558 | 204,368 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $8,790,274 | 424,651 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $8,231,483 | 437,845 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $6,784,075 | 470,463 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $13,042,601 | 751,302 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $17,149,291 | 824,089 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $20,135,188 | 856,088 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $20,405,264 | 730,586 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,000,541 | 769,254 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $25,096,162 | 743,590 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $39,419,761 | 1,128,536 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $32,246,579 | 1,059,001 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $53,329,358 | 1,626,391 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $50,180,669 | 1,658,317 | Shares | Other | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||